Dundalk based pharma-tech provider Diaceutics is to add 30 new jobs as the company seeks to expand globally.
Diaceutics uses diagnostics intelligence to connect medical patients to the right drugs. The company said the expansion will bring employment at the company to 100 before the end of 2018.
Diaceutics technology allows pharmaceutical companies to reach patients that need to be on specific drugs by helping them better understand testing for specific illnesses.
Diaceutics grew by 60pc in 2016 and the new expansion is set to focus on the areas of marketing and data analysis. The company currently counts 26 out of the world’s top 30 pharmaceutical companies as clients and provides oversight of testing in 23 markets.
The company also has a US headquarters in New Jersey as well as satellite offices in Asia and South America.
“Testing is now at the heart of pharmaceutical companies’ ability to identify the right patients for their new therapies,” said Peter Keeling, CEO of Diaceutics.
“We are uniquely positioned to provide the global testing perspective that allows this identification and treatment of patients who will benefit from specific and often life-saving drugs,” he added.
Diaceutics recently strengthened its senior management team with the addition of new domain experts. Dr Juliesta Sylvester is a new managing director of data and analytics, while Dr Peter Krein is the new managing director of client operations.